Do Options Traders Know Something About Alcon Stock We Don't?

03.07.25 22:49 Uhr

Werte in diesem Artikel
Aktien

98,12 CHF 1,32 CHF 1,36%

Indizes

1.252,2 PKT -0,5 PKT -0,04%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

8.580,2 PKT 28,7 PKT 0,34%

1.964,6 PKT -4,1 PKT -0,21%

11.972,4 PKT -6,0 PKT -0,05%

1.656,0 PKT -1,5 PKT -0,09%

16.605,2 PKT -12,0 PKT -0,07%

3.598,0 PKT 5,1 PKT 0,14%

4.464,8 PKT -20,9 PKT -0,47%

16.463,4 PKT -11,9 PKT -0,07%

7.178,3 PKT 32,1 PKT 0,45%

Investors in Alcon Inc. ALC need to pay close attention to the stock based on moves in the options market lately. That is because the July 18, 2025 $70 Put had some of the highest implied volatility of all equity options today.What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.What do the Analysts Think?Clearly, options traders are pricing in a big move for Alcon shares, but what is the fundamental picture for the company? Currently, Alcon is a Zacks Rank #3 (Hold) in the Medical – Instruments industry that ranks in the Bottom 24% of our Zacks Industry Rank. Over the last 60 days, no analyst increased the earnings estimates for the current quarter, while six have dropped their estimates. The net effect has taken our Zacks Consensus Estimate for the current quarter from 79 cents per share to 71 cents in that period.Given the way analysts feel about Alcon right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.Looking to Trade Options?Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. In addition to impressive profit potential, these trades can actually reduce your risk.Click to see the trades now >>5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Alcon (ALC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Novartis

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Novartis

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Novartis AG

Wer­bung

Analysen zu Novartis AG

DatumRatingAnalyst
10:26Novartis BuyDeutsche Bank AG
03.07.2025Novartis NeutralUBS AG
02.07.2025Novartis NeutralGoldman Sachs Group Inc.
01.07.2025Novartis NeutralUBS AG
19.06.2025Novartis BuyDeutsche Bank AG
DatumRatingAnalyst
10:26Novartis BuyDeutsche Bank AG
19.06.2025Novartis BuyDeutsche Bank AG
09.06.2025Novartis BuyDeutsche Bank AG
30.04.2025Novartis BuyDeutsche Bank AG
30.04.2025Novartis KaufenDZ BANK
DatumRatingAnalyst
03.07.2025Novartis NeutralUBS AG
02.07.2025Novartis NeutralGoldman Sachs Group Inc.
01.07.2025Novartis NeutralUBS AG
16.06.2025Novartis NeutralUBS AG
12.06.2025Novartis HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
DatumRatingAnalyst
21.11.2024Novartis UnderweightBarclays Capital
24.06.2024Novartis UnderweightBarclays Capital
23.04.2024Novartis UnderweightBarclays Capital
28.03.2024Novartis UnderweightBarclays Capital
06.02.2024Novartis UnderweightBarclays Capital

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Novartis AG nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen